Presenting state-of-the-art research and information, AIDS Education and Prevention integrates public health, psychosocial, sociocultural, and public policy perspectives on issues of key concern nationally and globally.
Evaluations of innovative and effective intervention programs.
Analyses of the full range of risk behaviors and processes.
Close examinations of the challenges facing particular communities.
Empirically based reviews of the efficacy of existing programs.
Special supplements providing in-depth coverage of essential topics.
Peter Aggleton, PhD, UNSW, Sydney, Australia
David Holtgrave, PhD, University at Albany School of Public Health, SUNY
Scott D. Rhodes, PhD, MPH, CHES, Wake Forest University
Richard Wolitski, PhD, U.S. Department of Health and Human Services
Editorial Board: Jose A. Bauermeister, Gauri Bhattacharya, Sheana Bull, John Chin, Nicole Crepaz, Mary Crewe, Mario De La Rosa, Danielle German, Perry N. Halkitis, Kenneth C. Hergenrather, Harm J. Hospers, Roger Ingham, Richard A. Jenkins, Trace Kershaw, Susan Kippax, Xiaoming Li, Sin How Lim, Gregorio Millet, Brian Mustanski, Ted Myers, Tooru Nemoto, Seth M. Noar, Ann O’Leary, Don Operario, Trinidad S. Osteria, Jeffrey T. Parsons, H. Fisher Raymond, Carlos E. Rodríguez-Díaz, Mary Jane Rotheram-Borus, Steven A. Safren, Inon Schenker, Julianne M. Serovich, Richard Sowell, Ron Stall, Patrick S. Sullivan, Lois Takahashi, Martha Ann Terry, McKinley Thomas, Ronald O. Valdiserri, Frank Y. Wong
Abstracts on Hygiene and Communicable Diseases, Addiction Abstracts, AIDS Abstracts, AIDS Newsletter, Bell & Howell Information and Learning, Cumulative Index to Nursing and Allied Health Literature, Current Contents/Social and Behavioral Sciences, EMBASE, EMcare, Index Medicus/MEDLINE, International Review of Psychiatry, MEDLARS, PsycINFO, Research Alert, Social SciSearch, Social Sciences Citation Index, Sociological Abstracts.
The impact factor of this journal is 1.904 and the 5-year impact factor is 2.702 [2019 Journal Impact Factor, Journal Citation Reports® (Clarivate 2020)].